New report reveals how abortion drug networks violate federal rules, put women in danger – LifeSite
(LifeSiteNews) — The online abortion pill market that has been established since the fall of Roe v. Wade has made circumventing state pro-life laws as simple as shopping on Amazon, without the medical safety considerations of legitimate healthcare, according to a new study of the digital landscape published on Tuesday by the pro-life Charlotte Lozier Institute (CLI).
The overview, authored by CLI research associate Mia Steupert, examines the “state of online abortion provision and access in America and the available online providers in and outside of the United States,” and “which providers, if any, follow the FDA’s [U.S. Food and Drug Administration’s] REMS [Risk Evaluation Mitigation Strategy] requirements.”
It identified eight online organizations that mail abortion-inducing drugs into states that prohibit them, found that 10 out of 28 websites warned of their conduct by the FDA in 2019 were “selling unapproved and misbranded abortion drugs” as late as March 2026 and that a mere 19 percent of online abortion drug sellers that report gestational ages comply with federal rules against shipping abortion pills after 70 days, or 10 weeks’ gestation.
The report details the various types of abortion pill suppliers operating through the internet, including virtual-only organizations that meet with women via webcam; hybrid brick-and-mortar centers that commit surgical abortions but also offer remote pill options; international organizations that rely on foreign medical licensing and peddle abortion drugs not approved at all by American authorities; often foreign e-commerce websites that operate with no medical supervision whatsoever and often little transparency in exchange for supplying pills “oftentimes as quickly as an Amazon transaction”; and loose community networks that supply donated or heavily-discounted drugs to women for free.
Providers in the last category, despite the activists behind them framing them as having charitable mission, “don’t require women to have a prescription when they email the network requesting abortion drugs, nor do any of the five existing community networks offer physician support if women experience post-abortive complications or have questions during or after the drug-induced abortion,” Steupert notes.
The report further notes that 17 of the entities allowed women to request abortion drugs without being pregnant at all, for future use, and another did not disclose whether or not they would comply with such requests. Out of nine that report whether or not they require women to provide identification, five did, three didn’t, and, for another, it varied by a woman’s home state. The remaining 33 did not report their ID requirements one way or the other.
Overall, the Biden-era relaxation of federal rules (which the Trump administration has so far refused to reverse) has led to a “subsequent increase in the proliferation of foreign and domestic online providers of abortion drugs, and the enactment of shield laws all contributed to a post-Dobbs landscape where abortion drugs are readily available on all corners of the internet to women in all 50 states and D.C.,” Steupert summarized.
“The egregious findings of this paper should serve as a wake-up call to policymakers that a wild west of online abortion drug access only serves to end unborn life at all costs, even at the expense of women’s safety,” she told the Daily Wire.
Mail-order pills have become the abortion lobby’s most potent tool for preserving abortion without Roe and make chemical abortions even in pro-life states extremely difficult to prevent. The latest data from the pro-abortion Guttmacher Institute found 1,125,930 clinical abortions in 2025, a slight increase from 2024, which Guttmacher attributed in large part to abortion pills. Planned Parenthood’s 2024-2025 annual report says that it alone committed 434,450 abortions, a record number for the organization and eight percent more than the previous year.
The abortion lobby aggressively supports pills despite their increased risk to abortion-seeking women. Pro-lifers point to an April 2025 analysis by the Ethics and Public Policy Center (EPPC), which concluded that almost 11 percent of women suffer sepsis, infection, hemorrhaging, or other major conditions after taking mifepristone, according to insurance data, plus similar findings by the Restoration of America Foundation, as part of a “growing body of evidence indicating that the health risks associated with mifepristone abortions are severe, widespread, and significantly underreported.”
Pro-lifers are currently waiting to see how the U.S. Supreme Court will rule on legal challenges to the FDA’s lax abortion-pill regulations, which allow the pills to be dispensed without an in-person medical visit, before a long-awaited Trump administration review of the safety data is finally released.
Recent Top Stories
Sorry, we couldn't find any posts. Please try a different search.












